29.	Supplemental data (unaudited)

The following information is presented as supplemental data as required by the indentures governing the Company’s Senior Notes.

Condensed Consolidating Statements of Income

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Patient services revenues	$	10,354,161		$	449,473		$	—		$	9,904,688
Less: Provision for uncollectible accounts		(451,353	)		(12,696	)		—			(438,657	)
Net patient service revenues		9,902,808			436,777			—			9,466,031
Capitated revenues		3,518,679			1,617,794			—			1,900,885
Other revenues		1,323,618			32,938			—			1,290,680
Total net revenues		14,745,105			2,087,509			—			12,657,596
Operating expenses and charges		12,850,562			2,035,001			110			10,815,451
Operating income		1,894,543			52,508			(110	)		1,842,145
Debt expense		(414,382	)		(10,140	)		—			(404,242	)
Other income, net		8,734			576			—			8,158
Income tax expense		455,813			10,643			(44	)		445,214
Net income		1,033,082			32,301			(66	)		1,000,847
Less: Net income attributable to noncontrolling interests		(153,208	)		—			—			(153,208	)
Net income attributable to DaVita Inc.	$	879,874		$	32,301		$	(66	)	$	847,639

Condensed Consolidating Statements of Comprehensive Income

	Consolidated Total			Physician Groups		Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Net income (losses)	$	1,033,082		$	32,301	$	(66	)	$	1,000,847
Other comprehensive losses		(29,627	)		—		—			(29,627	)
Total comprehensive income (losses)		1,003,455			32,301		(66	)		971,220
Less: Comprehensive income attributable to noncontrolling interest		(153,398	)		—		—			(153,398	)
Comprehensive income (losses) attributable to DaVita Inc.	$	850,057		$	32,301	$	(66	)	$	817,822

(1)	After the elimination of the unrestricted subsidiaries and the physician groups

Condensed Consolidating Balance Sheets

	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of December 31, 2016
Cash and cash equivalents	$	913,187	$	104,691	$	—	$	808,496
Accounts receivable, net		1,917,302		207,430		—		1,709,872
Other current assets		1,149,739		15,124		—		1,134,615
Total current assets		3,980,228		327,245		—		3,652,983
Property and equipment, net		3,175,367		1,378		—		3,173,989
Amortizable intangibles, net		1,527,767		4,858		—		1,522,909
Other long-term assets		650,578		78,215		2,714		569,649
Goodwill		9,407,317		16,405		—		9,390,912
Total assets	$	18,741,257	$	428,101	$	2,714	$	18,310,442
Current liabilities	$	2,696,445	$	223,302	$	—	$	2,473,143
Payables to parent		—		56,699		2,714		(59,413	)
Long-term debt and other long-term liabilities		10,221,813		44,094		—		10,177,719
Noncontrolling interests subject to put provisions		973,258		—		—		973,258
Total DaVita Inc. shareholders' equity		4,648,047		104,006		—		4,544,041
Noncontrolling interests not subject to put provisions		201,694		—		—		201,694
Shareholders' equity		4,849,741		104,006		—		4,745,735
Total liabilities and shareholder's equity	$	18,741,257	$	428,101	$	2,714	$	18,310,442

Condensed Consolidating Statements of Cash Flows

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2016
Cash flows from operating activities:
Net income	$	1,033,082		$	32,301		$	(66	)	$	1,000,847
Changes in operating and intercompany assets and liabilities and non-cash items included in net income		930,362			131,863			66			798,433
Net cash provided by operating activities		1,963,444			164,164			—			1,799,280
Cash flows from investing activities:
Additions of property and equipment		(829,095	)		(863	)		—			(828,232	)
Acquisitions and divestitures, net		(563,856	)		—			—			(563,856	)
Proceeds from asset sales		64,725			—			—			64,725
Investments and other items		126,558			(3,014	)		—			129,572
Net cash used in investing activities		(1,201,668	)		(3,877	)		—			(1,197,791	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(124,442	)		(4	)		—			(124,438	)
Intercompany		—			(143,837	)		—			143,837
Other items		(1,227,539	)		—			—			(1,227,539	)
Net cash used in financing activities		(1,351,981	)		(143,841	)		—			(1,208,140	)
Effect of exchange rate changes on cash		4,276			—			—			4,276
Net increase (decrease) in cash		(585,929	)		16,446			—			(602,375	)
Cash at beginning of the year		1,499,116			88,245			—			1,410,871
Cash at the end of the year	$	913,187		$	104,691		$	—		$	808,496

(1)	After the elimination of the unrestricted subsidiaries and the physician groups